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We have developed three types of experimental systems for the study of SCCL: (1) serially
heterotransplanted tumors in athymic nude mice; (2) continuous, clonable cell cultures; and (3)
direct clonogenic assays for tumor specimens. These systems have their own individual
advantages, applications, and limitations, but these are interrelated and complementary. The
study of these systems has greatly aided our understanding of the biology of SCCL, and its
relationship to other lung cancers and the APUD cell system. In addition, new markers for
SCCL have been identified, such as a creatine kinase and its BB isoenzyme (CK-BB). These
cellular markers may have clinical applications, as serum levels of CK-BB are an indicator of
tumor burden. Assays for clonogenic tumor cells may permit selection of optimal drug
combinations for the treatment of individual tumors. Variant cultures having the morphology
of SCCL, but lacking some or all of the other features, have been identified. While our systems
have been used primarily for biological studies, they have clinical applications for both
diagnostic and therapeutic purposes.
INTRODUCTION
Small cell carcinoma of the lung (SCCL) is one of the most fascinating of human
tumors. It is well established as a morphological, biological, and clinical entity,
distinct from other lung cancers. Initially, it was considered an undifferentiated
tumor that was associated with a variety of paraneoplastic syndromes caused by
"ectopic" hormone secretion. The discovery, in the late sixties, that some cells in most
of the tumors contained membrane bound, dense core, neurosecretory-like granules
[1,2] led to their inclusion in the amine precursor uptake and decarboxylation
(APUD) cell system of Pearse [3]. It was presumed that SCCL and bronchial
carcinoids arose from endocrine cells (Kultschitzky) in the normal respiratory
mucosa which expressed APUD properties [4]. Pearse postulated that all APUD cells
arose from the neural crest, and it was presumed that Kultschitzky cells and SCCL
had a different embryological origin from the rest of the endodermally derived
respiratory mucosa and non-SCCL lung cancers. However, as we learned more facts
about SCCL, it became even more enigmatic. Why did SCCL secrete some APUD
cell hormones frequently, and others seldom or not at all? Why did some SCCL
tumors contain non-SCCL elements, and how could some SCCL tumors undergo
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All rights of reproduction in any form reserved.morphological conversion to other tumor types, especially as the two groups were
supposed to be derived from different germ layers? Do all SCCL cells express APUD
properties, or only the small percentage that have visible neurosecretory granules? Is
SCCL a homogenous group of tumors, or can certain non-SCCL tumors mimic
SCCL morphologically? There are few endocrine cells inthe normal adult respiratory
tree, and the premalignant and early neoplastic changes of SCCL are not well
documented. Despite a few reports [5,6], suitable animal models are not generally
available or well studied. To further our understanding of the biology of SCCL, we
undertook the establishment and characterization of tissue culture cell lines from
human SCCL tumors.
THE BASIC APPROACH
Our basic approach was threefold: (1) heterotransplant lung tumors into athymic
nude mice and subpassage them; (2) establish continuous, clonable cultures of lung
cancers free of contamination by stromal cells and prove that these replicating cell
lines were malignant and had biochemical and morphologic features consistent with
SCCL; (3) clone lung cancer specimens directly in semi-solid medium. These
approaches have individual advantages and disadvantages, and are used fordifferent
studies. For these reasons, they are discussed separately. However, as will be shown
later, they are not entirely independent, and some studies require the use of more
than one type of approach.
While our studies concentrated on SCCL, tissue culture lines from non-SCCL lung
cancers were also established, and their properties were compared and contrasted
with those ofthe SCCL lines. Cell lines were established from primaryand metastatic
lung tumors from treated and untreated patients. Most non-SCCL lungcancers were
surgically resected specimens from untreated patients. Because SCCL and mesotheli-
omas are seldom resected, their cell lines were established from metastatic lesions of
treated and untreated patients, and included biopsies of bone, nodes, subcutaneous,
brain, and liver metastases and malignant effusions. Because SCCL are particularly
susceptible to damage by handling procedures, the most successful specimens were
those that required the least mechanical or chemical manipulations. These included
malignant effusions and bone marrow aspirates. The cells in these sites were relatively
viable, and were already disaggregated into single cells or small clusters. In addition,
tumor cells in effusions may be regarded as already having been adapted to "in vivo
culture" conditions, and were more easily adaptable to in vitro culture. The least
successful specimens were those comingfrom solid lesions such as node or subcutane-
ous metastases. These lesions frequently had extensive areas ofnecrosis, and required
considerable disaggregation, either mechanically or by trypsinization.
HETEROTRANSPLANTATIONS OF SCCL TUMORS
Athymic nude mice are suitable recipients for the heterotransplantation ofseveral,
but not all, human tumors[7,8]. The work ofseveral investigators indicates that nude
mice have some degree of resistance to heterotransplantation, and that such resis-
tance may be due to components of the immune system such as natural killer (NK)
cells [9,10]. We compared and contrasted the subcutaneous (sc) and intracranial (ic)
inoculation of SCCL tumors and cultures [11]. SCCL tumor specimens had a take
rate of 42 percent when inoculated sc, and 89 percent when inoculated ic. The sc
tumors grew as expansile, seldom invasive, non-metastasizing, and non-lethal
tumors. Failure to metastasize was not due to lack of vascular invasion, as tumor
emboli were present in the veins draining the tumors. In contrast to sc tumors, ic
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tumors required 10- to 1000-fold fewer tumor cells for successful takes. Ic lesions
invariably involved the meninges, with or without involvement and invasion of other
areas of the brain. They were invariably fatal, but they failed to metastasize to distant
locations. Extradural or solitary intracranial lesions were not observed. The histolog-
ical appearances of both sc and ic tumors were identical to those of the intermediate
subtype of SCCL, with inconspicuous nucleoli and scant cytoplasm, numerous
mitoses, extensive areas of necrosis, and DNA staining of elastic fibrils. The tumors
could be subpassaged with take rates of 100 percent, and could be established as
continuous cultures with take rates approaching 100 percent. Biochemical and
ultrastructural studies indicated that their properties were similar to those of fresh
and cultured tumors.
Sc tumors are useful for various biological and therapeutic studies, and for
growing large quantities of tumor cells. Ic inoculation is a useful tool, especially when
small numbers of tumor cells are available, and may provide a model for meningeal
carcinomatosis. Both inoculation sites provide further sources for the establishment
of continuous cultures.
PROPERTIES OF CONTINUOUS CELL CULTURES
We have established more than
35 continuous cultures from 30 patients with SCCL
[11,12].
While initial attempts to establish cultures were seldom successful
[12], with experience and development of newer techniques, we have boosted our
success rate to approximately 70 percent (provided the specimen contains adequate
numbers of viable tumor cells). SCCL cultures consisted of floating cell aggregates
which replicated relatively slowly and cloned at relatively low efficiencies. They were
aneuploid, had typical SCCL cytology, and induced tumors in nude mice having
typical SCCL histology. Non-SCCL lung cancer cultures were also aneuploid and
tumorigenic, but, in contrast to SCCL cultures, they demonstrated substrate adher-
ence and relatively short doubling times and high cloning efficiencies. These findings
are paradoxical, as the doubling time of SCCL tumors in patients is relatively short.
SCCL tumors and cultures have nutritional requirements that are different from
those of other forms of lung cancer [13], and our results suggest that routine culture
media may
lack one
more factors required for the optimal in vitro growth of
SCCL. As described below,
SCCL cultures have provided major new insights
regarding the biology of SCCL and its variants, about its relationship to other lung
cancers, and about APUD cells in general.
CLONOGENIC ASSAYS FOR SCCL TUMORS
We have adapted methods to grow human tumors directly in a clonogenic assay in
semi-solid medium [14,15] and we can successfully clone the majority of lung cancer
specimens [13,16].
A single cell suspension (about 105 cells/dish) is plated in layer
of 0.3 percent agarose in growth medium over a base layer of 0.5 percent agarose in
growth
medium. We have cloned 57/65 (88 percent) of specimens,
and 11/16
(69 percent) of non-SCCL lung cancer specimens. Colonies of SCCL contain 50 to
more than 1,000 cells. The colony-forming efficiency is relatively low for almost all
human tumors including
SCCL (0.003-0.36 percent). However,
many cells demon-
strate the ability to replicate for a limited number of times, with the formation of
clusters consisting
of less than 50 cells.
These cells are probably also replicating
tumor cells. Colonies be harvested with pasteur pipettes and characterized.
SCCL colonies had typical morphology,
including the presence of neurosecre-
tory granules. While only a few individual colonies (20/210) could be successfully
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cultured in liquid medium, pooled colonies from 8/10 (80 percent) specimens induced
tumors in nude mice after ic inoculation [11], confirming the stem cell origin of the
colonies. Cell cultures were established from grossly visible ic tumors, but not from
those that were microscopic, thus providing additional sources of continuous cul-
tures.
Clonogenic assays were developed to allow for eventual selection oftherapy for the
individual patient. They can also be used to screen new drugs. Our preliminary
observations using fresh specimens and established cell lines [DNC et al, unpublished
data], with drugs clinically useful in the treatment of SCCL (adriamycin, vincristine,
VP16, vindesine, and BCNU), indicate that tumors from untreated patients are
sensitive, while those from relapsed patients are resistant. Thus, our findings confirm
the clinical observation that relapsed SCCL tumors tend to be resistant to further
chemotherapy.
SELECTIVE GROWTH OF SCCL IN A DEFINED MEDIUM
We have developed a hormone supplemented, serum free, medium for the growth
of SCCL [17]. The medium consists of five components: selenium, hydrocortisone,
insulin, transferrin, and 17 B-estradiol (HITES). SCCL cell lines have been main-
tained in HITES for more than 12 months, with retention of their characteristic
morphological, ultrastructural, and biochemical features. Because HITES medium is
selective for SCCL, 14/15 (92 percent) of fresh SCCL tumor specimens propagated
successfully in it for periods of 3-15 weeks, and 10 of these specimens were
established as continuous cultures [13]. In contrast, the vast majority of non-SCCL
lung cancers and stromal cells do not replicate in HITES medium. Thus, use of this
medium is a highly selective method for the propagation of SCCL cells, and we have
used it for the rapid augmentation oftumor cells in specimens not otherwise adequate
for drug testing by clonogenic assays. In addition, HITES medium is useful for the
purification and identification of peptides and other SCCL cell products because, in
contrast to serum supplemented medium, it contains relatively few complex mole-
cules. We are currently exploring its use for the selective growth ofthe precursor cells
of SCCL present in the normal respiratory tree. In addition, we would like to develop
selective growth formulas for the other histologic types of lung cancer.
SCCL AND THE APUD CELL SYSTEM
The identification of neurosecretory granules and serotonin in some SCCL tumors
led Pearse to include them in his APUD cell system [3]. APUD cells are a diffuse
collection of cells scattered in many organs and having amine handling properties.
Pearse originally proposed that all APUD cells were derived from the neural crest,
but has recently modified his views [18] in the face of overwhelming evidence to the
contrary. We have summarized the evidence that SCCL and their presumptive
precursor cells are, like the rest of the respiratory tree, derived from endoderm [19].
This evidence includes failure to demonstrate the neuroectodermal origin of the
respiratory and GI endocrine cells, the relatively frequent presence of tumors of
mixed SCCL and other histologies, the in vivo and in vitro conversion of SCCL to
other tumor types, and the occasional expression of APUD cell properties by other
histological types of lung cancer.
Despite the continuing controversy regarding the APUD cell concept, SCCL cells
express the full range of APUD cell properties. While studies of clinical and autopsy
specimens [20,21] indicate a wide range of expression, SCCL cultures express them
uniformly [12]. Thus, all cultures have easily identifiable neurosecretory granules and
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very high levels of the key APUD cell enzyme L-dopa decarboxylase (DDC, EC
4.1.1.28). They fluoresce after exposure to formaldehyde vapor (indicating amine
precursor uptake and, perhaps, decarboxylation), and most secrete one or more
polypeptide hormones [12,22,23]. Analysis of more than 130 clones of seven SCCL
cultures indicated that high levels of DDC were retained in all cultures [AFG et al,
unpublished data]. In contrast, the clones had multiple patterns of polypeptide
secretion [24].
CREATINE KINASE-A NEW MARKER FOR SCCL
SCCL tumors and cultures are characterized by very high levels of creatine kinase
(CK, EC 2.7.3.2) predominantly in the form of its BB isoenzyme (CK-BB) [25].
Electrophoretic analyses of CK isoenzymes indicated that CK levels in SCCL were
quantitatively but not qualitatively different from those in normal lung and other
lung cancers. Because CK-BB is measured by a sensitive radioimmunoassay, while
total CK activity is measured enzymatically, we determined serum levels ofCK-BB in
67 untreated patients having SCCL. Elevated levels were present in 16/41 (39
percent) with extensive-stage disease, but in none of 26 (0 percent) of patients with
limited-stage disease. Our preliminary findings [DNC et al, unpublished observa-
tions] indicate that elevated serum levels reflect tumor bulk, and are present in only a
small percentage of patients having metastases in one site, while 100 percent of
patients with metastases to four or more sites have elevated levels. Serum levels may
also be used to monitor response to therapy, and relapse of tumor after therapy
induced remission.
SCCL TUMOR VARIANTS
While we have indicated above that SCCL cultures uniformly express APUD cell
properties and high levels of CK-BB, certain cultures, established from patients
having classical SCCL by light microscopic criteria, lacked these properties. Some of
the variants retained SCCL morphology and growth characteristics in culture, while
others did not. Ultrastructure of these tumors indicated that they consisted of
primitive cells lacking neurosecretory granules, but they had numerous desmosomes
and prominent bundles of filaments. By conventional ultrastructural criteria they
would be classified as poorly differentiated squamous cell carcinomas. Because they
have many of the features of the basal cells in the respiratory mucosa, the possibility
that they represent true undifferentiated tumors or perhaps "stem" cell tumors must
be considered. While these tumors are treated as SCCL, we do not as yet know
whether their response to cytotoxic therapy is similar to that of SCCL.
MORPHOLOGICAL AND BIOCHEMICAL CHANGES IN SCCL CELL LINES
SCCL tumors frequently undergo changes in morphology after therapy [26,27],
especially to large cell carcinoma, although virtually any form of lung cancer may be
represented. The change may be partial or complete. Morphological change is
accompanied by loss of the biochemical characteristics of SCCL. Similar changes
have been observed in our cell lines, including long-term cultures and heterotrans-
plants passaged many times [19,28]. In vitro changes are accompanied by loss of all
APUD markers, but high levels of CK-BB are retained, indicating discordant
regulation of the two enzyme markers CK and DDC [25]. Altered morphology in
vitro is accompanied by rapid growth, high cloning efficiencies, loss oftypical SCCL
morphology in in vitro culture and, sometimes, by an increase in DNA content. Our
interpretation of these changes is discussed below.
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THE NATURE OF SCCL AND ITS RELATIONSHIP TO
OTHER LUNG CANCERS
Our lung cancer cell lines, and similar ones established by others [22,23], have
greatly aided our understanding of a complex tumor. Because of the constant
biochemical and ultrastructural characteristics of SCCL, we regard it as a differen-
tiated tumor, closely related to other polypeptide secreting APUD tumors. We
presume it arises either directly from endocrine cells in the respiratory tree, or, more
likely, from common precursor cells committed to differentiation along endocrine
lines [19]. While the function of the Kultschitzky cells are not known, at least two
polypeptides, bombesin and calcitonin [29,30], are present inthem. We presume that
their function is the elaboration of multiple polypeptides that have nutritional or
differentiational effects on neighboring mucosal cells. Whether one type ofendocrine
cell exists in the lung or whether multiple functional forms occur is a moot point. We
further presume that elaboration of hormones by SCCL is an extension of the
function of their normal counterparts, and should not be regarded as "ectopic."
Altered morphology to large cell carcinoma with loss of biochemical and ultrastruc-
tural characteristics should be regarded as loss of differentiation. The presence of
other non-SCCL elements, both before therapy and, more frequently, after therapy,
suggests a close interrelationship between all forms of bronchogenic carcinoma.
Their presence cannot be explained on the basis of two separate embryological
origins for lung cancers. These changes may have clinical significance, as SCCL
tumors are therapy sensitive, while other forms of lung cancer are resistant. Human
tumor cell lines have greatly increased our knowledge and understanding of SCCL.
They also have clinical applications, both for diagnostic and therapeutic purposes.
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